Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stifel Financial Corporation Common Stock (NY:SF)

118.37 -0.06 (-0.05%)
Streaming Delayed Price Updated: 12:05 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stifel Financial Corporation Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Why Freshpet Was a Dog of a Stock This Week
Via The Motley Fool
Billionaires Sell Nvidia Stock and Buy a BlackRock ETF Wall Street Experts Say May Soar Up to 15,375%
Via The Motley Fool
Topics ETFs
Peering Into Stifel Financial's Recent Short Interest
 
Via Benzinga
Will the Stock Market Crash or Soar in 2025? Wall Street Has a Definitive Answer.
Via The Motley Fool
Forecasting The Future: 5 Analyst Projections For Stifel Financial
 
Via Benzinga
What Analysts Are Saying About Stifel Financial Stock
 
Via Benzinga
A Glimpse Into The Expert Outlook On Stifel Financial Through 9 Analysts
 
Via Benzinga
An Overview of Stifel Financial's Earnings
 
Via Benzinga
Analyst Scoreboard: 6 Ratings For Stifel Financial
 
Via Benzinga
Earnings Scheduled For January 29, 2025
 
Via Benzinga
Expert Ratings For Stifel Financial
 
Via Benzinga
Stifel Financial Corp: Chart Analysis
Stifel looks quite strong and I think this stock’s got some room to get up the $100 level... eventually. It's working taking a closer look. 
Via Talk Markets
Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today
Via The Motley Fool
This James Hardie Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
 
Via Benzinga
This Stock-Split Stock Could Crush the Market, According to Wall Street
Via The Motley Fool
Royal Caribbean Sails Onto The IBD 50: Build Your List Of Stocks To Watch With These Top IBD Screens
Royal Caribbean earns its spot on the Big Cap 20 with a best-possible 99 Composite Rating, putting it in the top 1% of all stocks. 
Via Investor's Business Daily
ASTRO America’s AM Forward Initiative Receives Final Approval for Private Equity Fund
--News Direct-- 
Via News Direct
Topics Economy
Decoding 4 Analyst Evaluations For Stifel Financial
 
Via Benzinga
History Says the S&P 500 Could Soar: 2 Monster Stocks to Buy Now
These growth stocks will help you profit from the current bull market. 
Via The Motley Fool
Topics Stocks
Can Carnival Stock Cruise Higher Next Week?
The largest cruise line operator has a big earnings report to announce before the next opening bell. 
Via The Motley Fool
Why Penumbra Stock Zoomed Nearly 5% Higher Today
The company might just be the right kind of business operating at the right time in history. 
Via The Motley Fool
Why Relay Therapeutics Plummeted by Nearly 14% Today
Investors weren't happy with the company's latest effort at capital-raising. 
Via The Motley Fool
Here's Why Birkenstock Stock Dropped Nearly 16% Last Month
When valuations are high, even little things can lead to disappointment. 
Via The Motley Fool
Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?
Find out how concerned investors should be about setbacks for this company's revolutionary new cancer therapies. 
Via The Motley Fool
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
3 Semiconductors Stocks to Buy Now: Q3 Edition
Whether your investment timeframe is months or years, these companies make for great options for semiconductor stocks to buy now. 
Via InvestorPlace
3 AI Stocks That Could Grow Your Wealth
Investors wanting exposure to the AI trade should consider these winning stocks, each of which can be expected to continue rising. 
Via InvestorPlace
Topics Artificial Intelligence
American Express To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
 
Via Benzinga
SF Stock Earnings: Stifel Financial Beats EPS, Beats Revenue for Q1 2024
SF stock results show that Stifel Financial beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Why Summit Therapeutics Stock Crushed the Market This Week
The company was a standout in the biotech field, rising by nearly 23% over the period. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.